Pegasys Long-Term Anti-Fibrotic Effect Co-Infection Trial (PERFECT)
NCT02762383
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
19
Enrollment
INDUSTRY
Sponsor class
Stopped
Low recruitment
Conditions
HIV/HCV Coinfection
Interventions
DRUG:
Peginterferon Alfa-2
Sponsor
Hoffmann-La Roche